Delivery Order SPE2DB24D3015-SPE2DB25FFYRT

Award Date 3/27/25
Potential Completion Date 4/17/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,082.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, a Delivery Order contract, is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $8,104.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product. The award has an ultimate completion date of November 27, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
This federal contract award, valued at $6,165.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,082.67 for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through February 3, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $6,165.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication, to support military healthcare programs. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,586.06 Firm Fixed Price Delivery Order is for BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 8, 2024 and was awarded on October 18, 2024. This award is a delivery order under AmerisourceBergen's larger $999,999,999 Indefinite Delivery...
This federal contract award, valued at $12,330.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $6,165.34 and is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This federal contract award, worth $3,082.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. The contract has an ultimate completion date of February 21, 2025 and is a firm fixed-price arrangement. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award, valued at $5,586.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. The award has an ultimate completion date of August 15, 2024, and is a firm fixed-price delivery order contract. This contract is not designated with a set-aside requirement, indicating open competition....
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFYRT
    Delivery Order

This federal contract award, valued at $3,082.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, with a period of performance through April 17, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive federal contract awards and Indefinite Delivery Contracts demonstrate its critical role in supplying essential medical products to various federal agencies, including the military and veterans' healthcare systems.

Generated 6/26/25, 9:44 AM